Moderna (MRNA) Cash from Financing Activities (2018 - 2026)
Moderna's Cash from Financing Activities was $14 million in Q2 2026, up 55.6% from $9 million a year earlier but down 17.6% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Cash from Financing Activities (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Moderna's Cash from Financing Activities was $611 million through Jun 30, 2026; for FY2025, it came in at $593 million, up 958.9% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -21.8% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $56 million in FY2024, -$1.38 billion in FY2023, -$3.45 billion in FY2022 and -$873 million in FY2021.
- Quarterly Cash from Financing Activities has moved between -$1.33 billion (Q2 2022) and $581 million (Q4 2025) over five years.
- Compared with a year earlier, Cash from Financing Activities was higher in two of the last four quarters, with growth averaging 58.9%.
- Per Business Quant data, MRNA's Cash from Financing Activities in the three quarters before Q2 2026 was $17 million (Q1 2026), $581 million (Q4 2025) and -$1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Moderna | 100.92 Bn | 80.27 Bn | 52.00 Mn | 14.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 17.00 Mn |
| Dec 31, 2025 | 581.00 Mn |
| Sep 30, 2025 | -1.00 Mn |
| Jun 30, 2025 | 9.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | -3.00 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 34.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | -109.00 Mn |
| Sep 30, 2023 | -58.00 Mn |
| Jun 30, 2023 | -668.00 Mn |
| Mar 31, 2023 | -542.00 Mn |
| Dec 31, 2022 | -438.00 Mn |
| Sep 30, 2022 | -1.04 Bn |
| Jun 30, 2022 | -1.33 Bn |
| Mar 31, 2022 | -642.00 Mn |
| Dec 31, 2021 | -873.00 Mn |
| Sep 30, 2021 | -2.00 Mn |
API Access
Moderna Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();